RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

GlaxoSmithKline PLC

A collection of news and information related to GlaxoSmithKline PLC published by this site and its partners.

Top GlaxoSmithKline PLC Articles

Displaying items 121-132
  • Swine flu seems to be trailing off -- for now, at least

     
    The current wave of pandemic H1N1 influenza infections is trailing off a little, the Centers for Disease Control and Prevention said this morning, and other indicators seem to confirm that diagnosis. In particular, the numbers of prescriptions written for...
  • Nearly 8,000 H1N1 flu deaths worldwide, WHO says

     
    At least 7,826 people worldwide have died from laboratory-confirmed cases of pandemic H1N1 influenza, an increase of more than 1,000 in the last week, but the actual number is probably much larger than that, the World Health Organization said today.......
  • 'Listening to Prozac' author feels 'vindicated' by new antidepressant study

     
    Peter D. Kramer, the psychiatrist and author of the path-breaking 1993 book "Listening to Prozac," said in an interview today that he felt "vindicated" by a newly published study ("Personality Change During Depression Treatment," by Tony Z. Tang et al)......
  • The Morning Fix: Drug company really wants to produce! Warner Bros. wants you to wait. Justice to review Comcast-NBC. Avatar heading to FX

     
    After the coffee. Before deciding if it'll be Alabama or Texas. (Hint: Texas) Warner Bros. wants you to wait. Hoping to boost DVD sales, Warner Bros. struck a deal with Netflix in which the online-DVD-rental powerhouse will agree to wait......
  • A documentary on obesity, brought to you by Big Pharma

     
    We love a good documentary as much as the next person and were intrigued when we got a news release touting a soon-to-be-made film exploring obesity helmed by none other than respected director-writer-producer Barry Levinson, who won an Oscar for......
  • Going through two tubes a week of Poligrip? You might want to reconsider.

     
    Denture wearers tend to want their dentures to stay in place. As this is not a fleeting or a temporary need, they must use adhesives for the long term. Some of them likely and perhaps understandably use too much. Don't,......
  • For benign prostate enlargement, a combination of drugs may be better

     
    A combination of drugs is better than either one alone for treating benign prostatic hyperplasia or BPH, an enlargement of the prostate gland that impedes normal urinary functions, researchers reported in the journal European Urology. The study is the...
  • The FDA warns against using Rotarix rotavirus vaccine--at least temporarily

     
    The Food and Drug Administration on Monday warned doctors and parents against using the Rotarix rotavirus vaccine until further testing can confirm that it is safe. The warning follows the discovery by an academic research group--subsequently confirmed by...
  • Glaxo Settles Avandia Lawsuits for $460 Million

    Glaxo Settles Avandia Lawsuits for $460 Million
    GlaxoSmithKline agreed to pay about $460 million to resolve a majority of lawsuits alleging the company's Avandia diabetes drug can cause heart attacks and strokes, people familiar with the accords said. Glaxo, the U.K.'s biggest drugmaker, agreed to...
  • The Avandia Dilemma

    The Avandia Dilemma
    The arthritis pill Vioxx was withdrawn but menopause hormones were not, even though both were tied to heart risks. A multiple sclerosis medicine was pulled and later allowed back on. So, when is a drug too risky to stay on the market? Drug safety...
  • For Diabetes Drug Avandia, Bad News Continues

    For Diabetes Drug Avandia, Bad News Continues
    The diabetes drug Avandia, once the world's top-selling diabetes medication, took two more hits Monday with one new study linking it to an increased risk of heart attacks and a separate study linking it to an increased risk of heart failure and stroke....
  • Experts Vote to Keep Avandia

    Experts Vote to Keep Avandia
    U.S. health advisers said GlaxoSmithKline Plc's GSK.L diabetes drug Avandia should be allowed to stay on the market in some form, easing a threat of further litigation that could have followed a ban. The 33-member panel of outside experts convened by the...